<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Reactive oxygen species may mediate tissue injury in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Aminosalicylates have <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity and the <z:chebi fb="11" ids="22586">antioxidants</z:chebi>, <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase and <z:chebi fb="0" ids="40279">allopurinol</z:chebi>, are of reported benefit in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To develop a convenient technique for testing the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> potential of standard and novel therapeutic agents for use in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Amplified chemiluminescence was used to measure reactive oxygen species production by colonic biopsy specimens from rats with <z:chebi fb="22" ids="15366">acetic acid</z:chebi> induced <z:hpo ids='HP_0002583'>colitis</z:hpo> and to assess the in vitro effect of conventional <z:chebi fb="11" ids="22586">antioxidants</z:chebi>, standard therapies and proposed novel therapies for <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The model was validated by demonstrating that the profile of effects on chemiluminescence of <z:chebi fb="22" ids="15366">acetic acid</z:chebi> induced <z:hpo ids='HP_0002583'>colitis</z:hpo> biopsy specimens given by conventional <z:chebi fb="11" ids="22586">antioxidants</z:chebi> (<z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="40910">azide</z:chebi>, catalase, copper-zinc <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase, <z:chebi fb="0" ids="28262">dimethyl sulphoxide</z:chebi>, <z:chebi fb="0" ids="28939">N-acetylcysteine</z:chebi> and <z:chebi fb="0" ids="22651">ascorbate</z:chebi>) and standard therapies (<z:chebi fb="0" ids="20551">5-aminosalicylate</z:chebi> and <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi>) resembled that previously reported using biopsy specimens from <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Human recombinant <z:chebi fb="70" ids="18291,35154">manganese</z:chebi> <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase did not alter chemiluminescence </plain></SENT>
<SENT sid="6" pm="."><plain>Two novel compounds, LY231617 (10 mM) and amflutizole (20 mM), reduced chemiluminescence by 98% (n = 5, p = 0.009) and 88% (n = 5, p = 0.03), respectively </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The similarity of the chemiluminescence responses of colonic biopsy specimens from <z:chebi fb="22" ids="15366">acetic acid</z:chebi> induced <z:hpo ids='HP_0002583'>colitis</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> to a range of conventional <z:chebi fb="11" ids="22586">antioxidants</z:chebi> and standard treatments suggests that this model is a useful method for testing the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> potential of new therapies for <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:chebi fb="11" ids="22586">antioxidant</z:chebi> actions of <z:chebi fb="0" ids="28262">dimethyl sulphoxide</z:chebi>, <z:chebi fb="0" ids="22651">ascorbate</z:chebi>, and the novel compounds, amflutizole and LY231617 in this model suggest that these agents merit further assessment in the treatment of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
</text></document>